Assessment of Invitro Anticancer Potential of Marine Derived Fungus Collected from South West Coast of Tamilnadu by Samuel, Ponpandian & Sudarmani, D.N.P.
Ivy Union Publishing | http: //www.ivyunion.org February 14 , 2016 | Volume 4 | Issue 1  
Samuel P et al. American Journal of Current Microbiology 2016, 4:1-9 Page 1 of 9 
 
 
Assessment of Invitro Anticancer Potential of 
Marine Derived Fungus Collected from South West 
Coast of Tamilnadu 
 
P. Samuel
1
 and D.N.P. Sudarmani
2
 
 
1
 Department of Biotechnology, Ayya Nadar Janaki Ammal College (Autonomous), 
Tamilnadu, India 
2
 Department of Zoology (PG), Ayya Nadar Janaki Ammal College (Autonomous), 
Tamilnadu India  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: marine sediment; Aspergillus flavus; Human breast adenocarcinoma cell line; IC50 
Peer Reviewer: Sihua Peng, Department of Biology, Shanghai Ocean University, China 
Received: November 20, 2015; Accepted: December 29, 2015; Published: February 14, 2016 
Competing Interests: The authors have declared that no competing interests exist. 
Copyright: 2016 Samuel P et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited. 
*Correspondence to: P. Samuel, Department of Biotechnology, Ayya Nadar Janaki Ammal college (Autonomous), 
Tamilnadu, India; Email: iprosamuel@gmail.com 
Research Article 
Abstract  
Cancer is currently one of the most globally prevalent diseases. Furthermore, the incidence of cancer is steadily increasing, 
accompanying the ageing and growth of populations, as well as imbalanced life-styles and declining environmental 
conditions. The present work describes the anticancer activity of marine sediment derived fungus obtained during the 
course of sampling. The marine sediment was collected from the south west coastal area of Tamilnadu. Sampling results in 
the isolation of 58 fungal species belongs to 37 genera. Among the 58 fungal isolates, the frequent fungus Aspergillus 
flavus was isolated from the sediment based on frequency of distribution, while it was cultured on Potato Dextrose Agar 
(PDA) amended with streptomycin 150 units/ml. The second half of the study was based on the production of secondary 
metabolites on  fermentation medium. The metabolites were concentrated using rotary vacuum evaporator. The anticancer 
activity of the metabolites was evaluated on human breast adenocarcinoma cell line purchased from National 
centre for cell sciences, Pune. Further the results revealed that the metabolite produced by the frequently isolated fungus 
has showed positive cell inhibitory effect on cell lines. The determined IC50 value of the metabolite was 29.03µg/ml. The 
study concludes that the marine derived organisms especially fungi is a promising agent to be exploited against the hunt for 
cancer drugs. 
American Journal of Current Microbiology 
http://ivyunion.org/index.php/ajcmicrob/ 
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Introduction 
Cancer is currently one of the most globally prevalent diseases particularly in developing country like 
India [1]. Cancer is considered a leading cause of death worldwide and estimates reports that, in 2030, 27 
million incident cases of cancer and 17 million of deaths are expected [2]. Furthermore, the incidence of 
cancer is steadily increasing, accompanying the ageing and growth of populations, as well as imbalanced 
life-styles and declining environmental conditions. The conventional treatment procedure of cancer is 
commonly (partially or solely) based on chemotherapy and radiation therapy. Several forms of 
chemotherapeutic drugs have been developed in order to combat cancer, such as alkylating agents, which 
damage the DNA, antimetabolite agents, which induce cell death at S phase and inhibit enzymes 
responsible for RNA and DNA synthesis, compounds that interfere with enzymes involved in DNA 
replication, mitotic inhibitors, which inhibit the progression of mitosis and associated enzymes and 
corticosteroids with cytotoxic and cytostatic activity [3] however, inability of the radiation to discriminate 
between normal cell from cancer cells hazardous side effects highlight the importance of the search for 
safer, more efficient and tumour-specific anticancer drugs. 
The marine environment is home to an immensely vast and complex array of species and ecosystems, 
most of which remain undiscovered. This does not come as a surprise, considering that the ocean covers 
approximately 70% of the planet’s surface. This massive body of water encompasses different ecological 
niches, some of which are highly productive and prosperous in biodiversity, such as the sea-land interface 
and deep ocean thermal vent communities, others, such as the vast open ocean waters, possess limited 
production and are poor in biomass and diversity. Appeltans et al., [4] enumerate a total of approximately 
226,000 described marine eukaryotic species, and estimate that one-third to two-thirds of marine species 
are yet to describe [4].  
The attention of the research is pulled towards to the marine environment, where the broad and yet to 
explore biodiversity make promise of new chemical structures. In spite of this interest, the hunt for marine 
natural products poses several challenges which limit its expansion; large and complex molecules, 
enhanced costs to collect and manipulate species, difficult to culture in laboratory conditions, the lack of 
technological tools and innovations and also environmental concerns [5]. In the last few years, marine 
fungi have gained a growing interest from the scientific community as sources of bioactive compounds of 
biotechnological interest. This interest rises from the fact that fungi produce secondary metabolites with 
potential concern in pharmacological and biological studies [6]. 
Marine microbes, particularly fungi, have recently been utilized as a new source of novel bioactive 
secondary metabolites [7, 8]. As evidenced by various research articles suggesting that the marine derived 
fungi could be a source of plethora of bioactive compounds and on the basis of the availability of less 
number of articles on the identification of lead molecules towards cancer, the present work is designed to 
isolate compounds with anticancer activity.  
Materials and Methods 
Collection of marine sediment 
Sediment samples were collected from different coastal lines  located along the south west coast of 
Tamilnadu, Kanyakumari (Dt). The samples were collected by Hand core pushing technique and 
transferred to a  sample carrier (purchased under UGC – SERO, Hyderabad Minor research Grant – 
Proposal number 231) and transferred to the laboratory in 24 hrs of duration.  
 
Analysis of Mycoflora 
Dilution  plating  technique  described  by [9]  was  used  to  isolate  the  fungi  from 
sediment sample.  Marine Sediment sampleswerediluted (1:1,000,    1:10,000 and 1:100,000) in 
sterilized seawater followed by 200 µL of diluted sample was inoculated  in Petri dishes containing 
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Potato Dextrose Agar (Himedia, Mumbai) culture medium. The inoculated plates were incubated in a dust 
free cubourd at the room temperature (26±2°C) for 7 days.  After the incubation, the development of 
fungal colonies were observed.  The fungal cultures were then transferred; subcultured and pure cultures 
were maintained. The semi-permanent slides were prepared using lacto phenol cotton blue staining 
method [10].  
 
Identification 
The slides were observed under microscope (Olympus cx22) under (400X) and identified with the help of 
keys given by [11-17] and following the taxonomic arrangement proposed in the 6th edition of Ainsworth 
and Bisby’s Dictionary of the Fungi [18]. 
 
Production of secondary metabolites 
Once all the fungus has been identified, a small tuft from the frequent fungi was separated from the well 
grown culture and aseptically transfers it in to a conical flask containing potato dextrose broth (Himedia, 
Mumbai)  prepared with sterilized sea water. It was incubated in a controlled environment for6 – 7 days 
at 30±2ºC. The change in the color of the medium indicated the production of secondary metabolites.  
 
Extraction of Secondary metabolites 
The production medium was gently filtered using whatmann No 1 filter paper and the filtrate was 
transferred into separating funnel mixed with ethyl acetate (a highly polar solvent) in a ratio of 1:1. The 
mixture was vigorously shaken at regular intervals (30 minutes) continuously for 8 hours. Later it was 
mounted in a stand and left the setup for overnight without disturbance. Next day, the organic portion was 
alone separated and concentrated using rotary vacuum evaporator.  
 
Separating Bioactive compounds 
Thin layer chromatography 
TLC is used to separate the compound present in the crude extract. The separation of the compound also 
depends on the usage of the specific solvent system. The drug with the concentration of  0.5 mg/mL was 
plotted on the TLC plate and dried. It was then run with different solvent ratio the spots were identified both 
in the UV light and in the iodine chamber. The Rf value was calculated using the formula: 
Rf value=Distance travelled by the solute / Distance travelled by the solvent 
 
Invitro cytotoxicity assay 
 
Methodology 
The human breast adenocarcinoma cell line (MCF7) was obtained from National Centre for Cell Science 
(NCCS), Pune and grown in Eagles Minimum Essential Medium (EMEM) containing 10% fetal bovine 
serum (FBS). All cells were maintained at 370 C, 5% CO2, 95% air and 100% relative humidity. 
Maintenance cultures were passaged weekly, and the culture medium was changed twice a week. 
 
Cell treatment procedure 
The monolayer cells were detached with trypsin-ethylene diamine tetra acetic acid (EDTA) to make single 
cell suspensions and viable cells were counted by tryphan blue exclusion assay using a hemocytometer. 
The cell suspension was diluted with medium containing 5% FBS to give final density of 1x105 cells/ml. 
one hundred microlitres per well of cell suspension were seeded into 96-well plates at plating density of 
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10,000 cells/well and incubated to allow for cell attachment at 370C, 5% CO2, 95% air and 100% relative 
humidity. After 24 h the cells were treated with serial concentrations of the metabolites. They were 
initially dispersed in phosphate buffered saline (PBS) and diluted to twice the desired final maximum test 
concentration with serum free medium. Additional four, 2 fold serial dilutions were made to provide a 
total of five sample concentrations. Aliquots of 100 µl of these different sample (metabolite) dilutions 
were added to the appropriate wells already containing 100 µl of medium, resulted the required final 
sample concentrations. Following metabolites addition the plates were incubated for an additional 48 h at 
370 C, 5% CO2, 95% air and 100% relative humidity. The medium containing without samples were 
served as control and triplicate was maintained for all concentrations. 
 
MTT assay 
3-[4,5-dimethylthiazol-2-yl] 2,5- diphenyltetrazolium bromide (MTT) is a yellow water soluble 
tetrazolium salt. A mitochondrial enzyme in living cells, succinate-dehydrogenase, cleaves the tetrazolium 
ring, converting the MTT to an insoluble purple formazan. Therefore, the amount of formazan produced 
is directly proportional to the number of viable cells. 
After 48h of incubation, 15µl of MTT (5mg/ml) in phosphate buffered saline (PBS) was added to each 
well and incubated at 370C for 4h. The medium with MTT was then flicked off and the formed formazan 
crystals were solubilized in 100µl of DMSO and then measured the absorbance at 570 nm using micro 
plate reader. The % cell inhibition was determined using the following formula.  
 
% Cell Inhibition = 100- Abs (sample)/Abs (control) x100.  
 
Nonlinear regression graph was plotted between % Cell inhibition and Log concentration and IC50 was 
determined using GraphPad Prism software. 
Results 
The preliminary isolation and morphological characterization procedure has led us to isolate 58 isolates 
belonging to 37 genera and on the basis of frequency of distribution, the fastidious fungi was identified as 
Aspergillus flavus (Fig 1a and 1b). The percentage (%) of distribution was estimated and given in Table 1. 
The production of secondary metabolites  and its characterization  by TLC revealed the presence of 
prominent compound (Fig 2a and 2b). The crude metabolite was concentrated and different dilutions 
6.25µg, 12.5µg, 25µg, 50µg and 100µg were prepared (Table 2a). The result has clearly showed that, as 
the concentration of the metabolite increases with increase in absorbance. No visible agglomerate was 
seen in the control as it does contain the metabolite. Simultaneously, the percentage of cell inhibition was 
also calculated. Remarkable changes were obtained when the concentration reaches 50 and 100µg/ml and 
between % Cell inhibition and Log concentration and IC50 was determined using GraphPad Prism 
software the IC50 were found to be 29.03 µg/ml (Table 2b and Fig 3).  
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Table 1 List of taxonomic group of fungi and its individual contribution 
 
 
 
 
 
 
 
 
 
 
 
Table 2a Concentration of the metabolites against the absorbance 
 
Conc 6.25 µg 12.5 µg 25 µg 50 µg 100 µg Cont 
ABS 0.535 0.521 0.446 0 0 0.548 
 
0.537 0.509 0.478 0 0 0.544 
 
0.55 0.51 0.469 0 0 0.538 
Avg 0.540667 0.513333 0.464333 0 0 0.543333 
 
 
 
Table 2b Concentration of the metabolite (µg/ml) and % of cell inhibition 
 
Conc (µg/ml) % Cell Inhibition 
    6.25 0.490798 
 
IC 50 29.03 µg/ml 
12.5 5.521472 
    25 14.53988 
 
R² 0.9971 
 50 100 
    100 100 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Taxonomical group of fungi 
Individual contribution 
(%) 
1 Ascomycota 48 
2 Mucoromycotina 2 
3 Mitosporic fungi 5 
4 Anamorphic fungi 2 
5 Hyphomycetes 1 
 
 
Fig 1a. Plate image of 
Aspergillus flavus on potato 
dextrose agar 
 
 
Fig1b.  Microscopic observation of 
Aspergillus flavus [400X] 
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Fig 2a Production of secondary 
metabolites on Potato dextrose broth by 
Aspergillus flavus 
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Discussion 
Distribution of filamentous fungi in the present study has shown a higher diversity. Of the 58 isolates 
belonged to 37 genera comprising 48% Ascomycota, 2% Mucoromycotina, 2% Anamorphic fungi, 1% 
Hyphomycetes and 5% Mitosporic fungi (Table 1). However, the present study matches the findings of 
several investigators who found Ascomycetes fungi as the major contributor to the filamentous higher 
marine fungi [16 , 19, 20]. 
 
According to a report submitted by Mathan et al., [21],  that 200mg of the compound from marine 
sediment derived Aspergillus protuberus sp1 was required to evaluate the anticancer activity in albino 
mice, but in the present study the compound produced by Aspergillus flavus was required in  least 
concentrations  ranging from 6.25µg to 100 µg. It indicates that the Aspergillus flavus has potent 
inhibitory nature against cancer cell lines.  
 
Another study conducted by Bhimba, et al., [22], reported that 125 μg/mL of the compound from Irpex 
hydnoides - endophytic fungi was required to achieve 50% cell viability inhibition but in the present study 
revealed that about 29.03 µg/ml concentration was able to bring effective cell inhibition. This result has a 
promising output towards the identification of targets and possible exploitation of sediment derived fungi 
against cancer.  
 
According to a research conducted by Abo-Kadoum et al., [23], reported they had evaluated the crude 
extract of Penicillium aurantiogriseum against hepatic cellular carcinoma (HEPG2). The cell line was 
treated with serial concentrations of 6.25, 12.5, 25, 50 and 100 µg/ml as the dilution procedure adopted in 
the present investigation. The result has revealed that the maximum concentration 100 μg/ml killed 
82.76 % of the viable cells, while the minimum concentration 6.25 % killed 52.54% of the viable cells. In 
the present investigation, under 100 μg/ml, all the viable cells were completely inhibited and least 
inhibition was observed in 6.25 μg/ml is about 0.490798. The results are entirely differing from the 
available reports on drugs against cancer research.  
Conclusion  
The results of  present study revealed that Aspergillus flavus is a potent producer of safe bioactive 
compounds which can be used as an anticancer compound. Further studies are required to separate, 
identify and purify these compounds  and determine  the right compound has the biological activity to 
use in biomedical application. 
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